ImmunoPrecise Antibodies adds scientific depth to board with new director

He is an emeritus professor at the University of Victoria, where he was a faculty member for over 35 years.
ImmunoPrecise Antibodies adds scientific depth to board with new director
Dr Burke fills the vacancy left by Thomas D'Orazio, who has left as director, the group said.

Immunoprecise Antibodies Ltd (CVE:IPA, OTC PINK:IPATF) has appointed Robert Burke as a director to help the firm assess the scientific efficacy of its strategic acquisitions globally.

Dr Burke fills the vacancy left by Thomas D'Orazio, who has left as director, and brings significant scientific depth and experience in the production and characterization of antibodies, the firm said.

He is an emeritus professor at the University of Victoria, where he was a faculty member for over 35 years.

He has published over 100 peer-reviewed publications and has supervised numerous trainees.

"With the appointment of Dr. Robert Burke to the board of directors, IPA continues its history of bringing leading scientific capability to assist the company to become a leading integrated antibody solutions company with global reach," said Dr James Kuo, chairman and interim president of the company.

Immunoprecise Antibodies Ltd shares added 1.92% in Toronto to C$0.53.

View full IPA profile View Profile

Immunoprecise Antibodies Ltd Timeline

Related Articles

cancer cells from taken by an electron microscope
March 13 2018
Sareum has partnered with Sierra Oncology to advance the company's Checkpoint kinase 1 inhibitor
1528098797_Biotech-lab.jpg
June 04 2018
While tricky, the last year has seen Abzena increase its customer engagement with its integrated discovery, development and manufacturing service offering
test tubes
January 22 2018
Under former chief executive Peter George and his successor Shaun Chilton, it has been transformed via a series of well-judged, quickly integrated and, crucially, cash generative acquisitions

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © personabelovo.ru, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated.